Royal DSM's $360M Kensey Nash bid will close in a few days; MIT scientists creating sharper ultrasound imaging tech;

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @MarkHFierce: Our coverage of the 2012 BIO International Convention continues. Roundup | Follow @MarkHFierce

> The rise in molecular diagnostics testing helped contribute to 96,000 biosciences jobs created in the U.S. from 2001 through 2010, even as private-sector jobs otherwise declined, according to a new report from the Biotechnology Industry Organization and the research firm Batelle. Story

> Investors are driving D. Medical Industries shares higher after the Israeli company disclosed it is negotiating to possibly buy a diabetes devices company. Item

> Venture capitalists are increasingly turning to startups that make smartphone and tablet apps for doctor and hospital use, Bloomberg reports. Story

> AdeTherapeutics, a developer of products designed to reduce post-surgical adhesion complications, has hired a number of renowned physicians for its "clinical execution team." Release

> Massachusetts Institute of Technology researchers are working on developing sharper ultrasound imaging technology in a bid to improve the diagnostic tool. Story

Biotech News

@FierceBiotech: The Fierce team has landed in Boston. Check out our dedicated BIO2012 page. Special Coverage | Follow @FierceBiotech

@JohnCFierce: Thanks to Bernard Munos, Jim Burns, Jason Gardner, Jill Milne, Mene Pangalos and 300+ of my closest friends for a great conversation this a.m. | Follow @JohnCFierce

@RyanMFierce: Danish biotech Nuevolution snagged €11 Million in new financing round. Release | Follow @RyanMFierce

> Millennium wants to rival top 10 drugmakers in oncology. Story

> E&Y: Biotech looks stable, but warning signs cloud the future. Article

> Novartis, Emergent headline $400M HHS plan to combat health threats. News

> Roche, Seaside join forces against autism and Fragile X. More

> Biotech beats overall economy in jobs report. Item

Pharma News

@FiercePharma: Will Human Genome's bid deadline backfire? Or will GSK be thwarted by some secretive white knight? Report | Follow @FiercePharma

> With Brennan gone, AstraZeneca megamerger talk can resume. Article

> No overtime for pharma reps, Supreme Court says. Story

> Merck Serono's final answer: Geneva HQ will close. News

 

Biotech Research News

> In life sciences R&D, China is reaching for the stars. Editor's corner

> Pluristem's placental stem cells spur bone marrow growth. Story

> Genetic markers uncovered for rare children's brain tumor. Report

> Breakthrough: Human Microbiome Project maps healthy body microbes. More

Pharma Manufacturing News

> Amneal Pharmaceuticals quadruples manufacturing. Item

> Just about everyone agrees: drug shortages are a complex puzzle. Story

> Canadian Internet pharmacy leader faces federal charges. Article

And Finally... Royal DSM's ($DSM) plans to pay $360 million for Kensey Nash ($KNSY), a regenerative medicine-focused medical device company, and looks to close its offer within a few days. Release

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.